Pharma Reviews: India better placed to reap benefit of biologics patent expiry: say experts

It will help Indian biosimilar industry attract more investment and reap ... on copies of biosimilars has provided Indian pharma tremendous opportunity.
Read more: India better placed to reap benefit of biologics patent expiry: say experts